Search

everythinglearnresearchcommunity

for

Search:↓

Skin grafts from related donors significantly healed chronic wounds in patients with a severe skin condition over a year.

Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Patients with hidradenitis suppurativa have higher levels of cell-free DNA in their blood.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

Enhancing cannabinoid signaling may help treat skin inflammation.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

The document suggests that nerve issues might contribute to hair loss and that testing sensation could predict these nerve problems.

Microneedle patches with different pore sizes can effectively deliver drugs and trigger strong immune responses.

Smaller nanoemulsions can penetrate skin and hair follicles better, which may be useful for delivering drugs and vaccines through the skin.

Hair follicles help skin immune recovery after UVB exposure.

Stress hormones and autoimmune reactions can cause hair loss.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Stem cell treatment from umbilical cords reduces symptoms of atopic dermatitis and may help hair growth.

Chitosan–hydroxyapatite biocomposites are promising for tissue engineering due to their safety and ability to support healing.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Exosomes from certain cells can improve hair regrowth by changing the immune response.

PRP shows promise in healing and regeneration but needs standardized protocols for consistent results.

Vitiligo treatments are improving but relapses are common.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

Blocking LFA-1 prevents hair loss in mice.

Tiny vesicles from stem cells could be a new treatment for healing wounds.